Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may impair skin vessel responses by damaging

During therapy, repeated heating and cooling may chemically damage in skin vessels, weakening their sustained response despite preserved initial and sweating. No chemical change or , with sufficiently precise measurements, would reject this mechanism.

Stage of verification

  1. Hypothesis published2026-09-26
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionHeart and blood vessels

Ageing mechanism

Main connectionLoss of proteostasis

Direction

Kind of knowledge gap

The available measurement is only an indirect stand-in for what matters.Proxy gap

A double ring marks the main placement where a group contains several values.

Lens
Biochemical damage accumulation
Goal
Идентификация терапии с десятилетним восстановлением функций кожи
Competing hypotheses
2
Published
2026-09-26
As a hypothesis
8 / 10Clarity of mechanism
6 / 10Few extra conditions
5 / 10Completeness of the answer
6 / 10Novelty of the idea
7 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research
Poster: Thermal cycles impair skin-vessel responses
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Enzyme

    An enzyme that synthesizes

    Where this hypothesis actsSkin blood vessels during repeated heating and cooling cycles under therapy

    Hypotheses on this target 1
    Nitric oxide synthaseInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Restore coupled enzyme function

    With whatNot stated in the record

    HowThe restoration method is not specified; the intervention is proposed to leave the intact

    Possible result

    Possible stabilization of and improved maintenance of the during thermal loading

    From the recordВосстановление сопряжённой работы фермента должно стабилизировать SPV_8 без вмешательства в эпидермальный барьер.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthase
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin that functions more like younger skin would also need to release heat effectively. The unexpected move is to propose that repeated heating and cooling during treatment leave lasting chemical damage in the machinery that keeps skin blood vessels widened, even after the applied formulation changes. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Repeated heating and cooling during treatment are proposed to accumulate chemical changes in the machinery that produces the vessel-widening signal .
  2. Those changes are proposed to turn coordinated enzyme operation into disrupted operation that cannot sustain the same vessel response.
  3. Skin vessels are predicted to widen initially, and sweat production to remain intact, while maintained widening progressively deteriorates.
  4. The chemical changes are proposed to retain the effect of earlier temperature exposures after the applied formulation changes or allows water vapour through more readily.
  5. Within a period when repair between cycles is negligible, each is predicted to contribute its independently calibrated share of damage; rearranging the same cycles should leave the final deficit unchanged.
  6. Restoring coordinated enzyme operation is predicted to stabilize , an outcome measure left undefined in the supplied material, without changing the or requiring alignment of blood-flow and sweat rhythms.
A picture for it

The proposed accounting resembles a punch card: different temperature cycles use up different numbers of spaces, and changing their order leaves the same number filled. Changing the skin formulation is like changing the card's sleeve; it does not erase the marks already made.

Where the picture breaks: Living tissue can repair itself, and one exposure can alter the effect of the next. The proposal therefore restricts this additive rule to periods with negligible repair and treats an effect of cycle order as evidence against the rule.

  1. Master questionstep 01 of 04

    A treatment is sought that would bring the functional condition of middle-aged people's skin closer to that of younger people.

    Rests on: The goal itself identifies the population and the intended comparison with younger skin.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    The treatment goal adds a ten-year restoration of skin function, without specifying whether this means reversing ten years of change or maintaining improvement for ten years.

    Rests on: The master question supplies the aim of restoring younger function, but supplies no ten-year criterion.

    Assumption

    A ten-year target is introduced without a stated justification or an operational definition of what the ten years measure.

  3. Gap questionstep 03 of 04

    A treatment might hinder sweat evaporation and thereby reduce heat loss despite normal sweat production. Selectively removing that resistance is proposed as a way to restore a younger heat response while preserving the .

    Rests on: The preceding goal calls for restored skin function, but does not identify a treatment or establish that it obstructs evaporation.

    Leap

    The missing bridge is a stated reason to expect the candidate treatment to create resistance to evaporation and a hidden heat-loss deficit. Neither the preceding stage nor the supplied screened findings establishes that connection.

  4. Hypothesisstep 04 of 04

    Repeated heating and cooling during treatment are proposed to cause , a chemical alteration through oxidation, of , the enzyme machinery that produces , a signal that helps blood vessels widen. The proposed damage disrupts , the coordinated operation needed to produce that signal: initial widening and sweating remain intact, but sustained widening deteriorates and the deficit persists after the formulation changes.S1S2

    Rests on: The preceding question supplies the heat-loss problem; the proposed chemical explanation draws on separate biological observations. S1, in Journal of Applied Physiology (2012), reports a role for this enzyme in widening skin vessels during local heating and a reduced response in middle-aged skin, but does not test repeated cycles or chemical damage. S2, in Microvascular Research (2015), suggests that oxidation-related stress could disrupt the enzyme in people with high blood pressure, but does not establish that mechanism or its accumulation during treatment.

    Supported by literature

What is carried, and what is not. Screened sources support separate ingredients, not the proposed sequence: alongside S1's heating response and S2's suggested chemical route, S6, an abstract in American Journal of Physiology—Heart and Circulatory Physiology (2026), reports that increased 's contribution to the response, but does not establish accumulated cycle damage or restored . No supplied source establishes the chain end to end; S5, an abstract in Microvascular Research (2015), reports no difference in its vessel-response measure between heating bouts, limiting any general claim that reheating necessarily worsens the response without testing the proposed treatment-dependent accumulation.S1S2S6S5

Where the reasoning is carried by something unstated · 2
  • Goal pillar. A ten-year target is introduced without a stated justification or an operational definition of what the ten years measure.
  • Gap question. The missing bridge is a stated reason to expect the candidate treatment to create resistance to evaporation and a hidden heat-loss deficit. Neither the preceding stage nor the supplied screened findings establishes that connection. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A successful fit to accumulated exposure could be mistaken for evidence of additive chemical damage if the same mixed sequences are used to adjust the model, or if repair and cycle order alter the response. What closes it: The design already requires independent calibration and prediction without refitting. Cycle classes, the deterioration criterion and measurement precision must be fixed beforehand; rearrangements of identical cycle sets must be compared, and negligible repair over the selected interval must be established. The proposed damage score sums each cycle count divided by its independently measured count to deterioration; its threshold of one is a model prediction, not an established biological boundary.
  • Improvement after an attempted enzyme repair could be credited to restored chemical function even if it instead changes the timing between blood flow and sweating, or changes how much incoming light the formulation absorbs. Conversely, a failed repair could be mistaken for a failed hypothesis when the intervention never restored enzyme operation. What closes it: Restoration of must be measured alongside the sustained vessel response. Comparisons must hold the current formulation and final heat exposure constant, measure the relative timing of blood flow and sweating, and control incoming light and formulation absorption. A negative intervention result requires evidence that its intended chemical target actually changed.
  • A better vessel response could be mistaken for restored heat loss or younger overall skin function. The proposal names without defining it, so its improvement alone cannot establish those outcomes. What closes it: , its measurement method and the younger comparison range must be defined before testing. Heat loss, sweat production, evaporation and the must be assessed separately; initial vessel widening must also be distinguished from its maintenance during the load.

What would make this wrong. With sufficiently precise measurements and verified delivery of the intended temperature exposures, absence of both the proposed chemical change and an accumulating sustained-response deficit would refute the mechanism under those tested conditions. A deficit that follows only the current formulation or the timing of blood flow and sweating, without the proposed chemical change, would instead support a rival explanation. Different outcomes from rearranging the same cycles would specifically refute the borrowed additive rule, while leaving other forms of cumulative biological damage unresolved.

What it would change. If the hypothesis held, restoring younger skin function would require accounting for prior temperature exposure and persistent changes in blood-vessel regulation, as well as the treatment's present effect on evaporation. A formulation that permits more evaporation could leave an accumulated vessel deficit unresolved. The proposed first tests use tissue models supplied with flowing fluid, so success there would still leave restoration in middle-aged people, preservation of the protective barrier and the undefined ten-year target unestablished.

Sources read · 10

4 literature searches, 8 full texts, 2 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Endothelial nitric oxide synthase mediates cutaneous vasodilation during local heating and is attenuated in middle-aged human skin. · Journal of applied physiology (Bethesda, Md. : 1985) · 2012

“These data suggest that eNOS mediates the production of NO during local heating and that cutaneous vasodilation is attenuated in middle-aged skin.”

Does not settle: Источник не изучал повторные циклы нагревания и охлаждения, терапию, окислительное повреждение или сопряжение ферментного комплекса, потоотделение, сохранность начального ответа, ухудшение ответа по ходу минутной нагрузки, перенос состояния между носителями, SPV_8 или восстановление функции фермента.

S2Partly answers it

Altered skin flowmotion in hypertensive humans. · Microvascular research · 2015

“3) increase oxidative stress causing eNOS-uncoupling and reducing NO production, and/or 4) increased oxidative stress creating a favorable environment for the generation of pro-constrictor endothelium derived contracting factors.”

Does not settle: Источник лишь предполагает связь окислительного стресса с разобщением eNOS и снижением продукции NO у людей с эссенциальной гипертензией при локальном нагревании. Он не устанавливает эффект повторных циклов нагревания и охлаждения, терапии или смены носителя, накопление повреждения, сохранность потоотделения, динамику поддержания сосудистой реакции, показатель SPV_8 или эффективность восстановления сопряжённой работы фермента.

S3Partly answers it

Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction. · International journal of cardiology. Heart & vasculature · 2023

“5-FU presented with diminished microvascular reactivity following eNOS-dependent local heating compared to CON (P=0.001).”

Does not settle: Источник не устанавливает эффекты повторных циклов нагревания и охлаждения, окислительную модификацию или разобщение ферментного комплекса, секрецию пота, ухудшение ответа в течение минутной нагрузки, зависимость от последовательности воздействий или смены носителя. Он также не оценивает восстановление сопряжённой работы фермента, SPV_8 и эпидермальный барьер.

S4Contradicts it

Skin blood flow and nitric oxide during body heating in type 2 diabetes mellitus. · Journal of applied physiology (Bethesda, Md. : 1985) · 2009

“However, the relative contribution of nitric oxide to the cutaneous vasodilator response (expressed as % of maximal cutaneous vascular conductance) was not different between groups ( P > 0.05).”

Does not settle: The source studies 45–60 minutes of whole-body heating in people with type 2 diabetes and age-similar controls. It does not test repeated heating-cooling cycles, therapy, cumulative oxidative damage or uncoupling of nitric oxide synthase, sweat secretion, persistence after changing a carrier, SPV_8, epidermal barrier effects, or restoration of enzyme coupling.

S5Contradicts itAbstract only

To reheat, or to not reheat: that is the question: the efficacy of a local reheating protocol on mechanisms of cutaneous vasodilatation. · Microvascular research · 2015

“In protocol 1, there were no differences (P>0.05) in CVC at either the forearm (88±4 vs. 86±4%max) or the leg (97±4 vs. 96±6%max) between heating bouts.”

Does not settle: Аннотация не устанавливает наличие или отсутствие окислительной модификации ферментного комплекса, переноса эффекта между носителями, изменений потоотделения, накопления повреждения при терапии или влияния восстановления сопряжённой работы фермента на SPV_8.

S6Partly answers itAbstract only

Relative contributions of mitochondrial and nonmitochondrial oxidative stress in age-related cutaneous microvascular endothelial dysfunction. · American journal of physiology. Heart and circulatory physiology · 2026

“Tempol improved the NO contribution to the response compared with Ringer's (61.40 ± 15.92 vs. 37.02 ± 20.64, P = 0.01), but MitoTempo (P = 0.69) did not.”

Does not settle: Абстракт не устанавливает последствия повторных циклов нагревания и охлаждения, роль терапии или смены носителя, накопительное химическое повреждение и окислительную модификацию сопряжения синтазы оксида азота. Он также не описывает потоотделение, динамику поддержания ответа в течение минутной нагрузки или показатель SPV_8.

S7Background

Skin pigmentation is negatively associated with circulating vitamin D concentration and cutaneous microvascular endothelial function. · American journal of physiology. Heart and circulatory physiology · 2022

“After attaining stable elevated blood flow, 15 mM N G -nitro- l -arginine methyl ester ( l -NAME; NO synthase inhibiter) was infused to quantify %NO-mediated vasodilation.”

Does not settle: Источник не устанавливает влияние повторных циклов нагревания и охлаждения, терапии, окислительного повреждения или разобщения синтазы оксида азота. Он также не оценивает сохранение эффекта после смены носителя, потоотделение, ухудшение ответа во времени, SPV_8 или восстановление сопряжённой работы фермента.

S8Background

Apocynin and Tempol ameliorate dietary sodium-induced declines in cutaneous microvascular function in salt-resistant humans. · American journal of physiology. Heart and circulatory physiology · 2019

“These findings provide direct evidence of dietary sodium-induced endothelial cell oxidative stress and suggest that NADPH-derived reactive oxygen species contribute to sodium-induced declines in microvascular function.”

Does not settle: It does not test repeated heating-cooling cycles, therapy-related accumulation, nitric oxide synthase uncoupling or oxidative modification of its complex, sweat secretion, response maintenance over minutes, carrier transfer, epidermal barrier effects, or SPV_8.

S9Background

Inhibition of superoxide and iNOS augment cutaneous nitric oxide-dependent vasodilation in non-Hispanic black young adults. · Physiological reports · 2024

“we recognize that we cannot directly assert whether oxidative or nitrosative stress contributed to the current findings.”

Does not settle: This source does not establish effects of repeated heating-cooling cycles, therapy exposure, oxidative modification or uncoupling of a nitric oxide synthase complex, sweat responses, response persistence after carrier changes, SPV_8, or restoration of enzyme coupling.

S10Background

Quantification and interpretation of nitric oxide-dependent cutaneous vasodilation during local heating. · Journal of applied physiology (Bethesda, Md. : 1985) · 2024

“Human cutaneous microdialysis approaches for assessing nitric oxide (NO)-dependent blood flow include local heating (LH) of the skin until a plateau is reached, followed by infusion of a NO synthase inhibitor such as N G -nitro- l -arginine methyl ester ( l -NAME); however, varied methods of quantifying and expressing NO-dependent vasodilation can obfuscate data interpretation and reproducibility.”

Does not settle: Источник не устанавливает влияние повторных циклов нагревания и охлаждения или терапии на окислительное повреждение синтазы оксида азота, сопряжение фермента, потоотделение, динамику сосудистого ответа, перенос эффекта между носителями, SPV_8 либо эпидермальный барьер.

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

Does easing treatment-created resistance to sweat evaporation restore youthful cooling in middle-aged skin while preserving its protective barrier?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Определяет ли , создаваемое терапией, скрытую потерю при нормальном потоотделении, и восстановит ли его избирательное снижение молодой тепловой ответ без утраты ?

What this question is asking

The question asks whether a skin treatment could hinder cooling even when the skin produces a normal amount of sweat. It assumes that the treatment creates resistance to evaporation, meaning that sweat has more difficulty changing into water vapour and carrying heat away. It asks whether selectively reducing that resistance in middle-aged people would restore the cooling response of young people within a specified period measured in minutes, while preserving the treatment's protective barrier effect, skin sensitivity and ability to tolerate exertion. The relevant comparison is actual heat loss with and without that reduction, judged against a young reference group; the supplied material does not specify the treatment, time window or criteria for restoration.

What the terms mean
Resistance to evaporation
An obstacle to liquid water becoming water vapour and moving away from the skin. The question proposes that a treatment creates this obstacle, but the supplied sources do not establish that.
Sweat production
The amount of sweat released onto the skin over time. Producing sweat and evaporating it are distinct steps; the question asks whether the first can appear normal while cooling through the second is limited.
Evaporative heat loss
Heat removed when water changes from liquid to vapour. Here it refers principally to cooling as sweat evaporates from the skin.
Dry heat loss
Heat transfer that does not depend on water evaporating. It is included alongside evaporative heat loss in the whole-body measurements described by S1 and S7.
Direct calorimetry
A method that measures heat leaving the body. S1 uses it to assess total heat loss rather than relying only on sweat production as an indirect indicator.
Protective barrier effect
The protection that the skin treatment is intended to provide and retain. The supplied material does not specify which protective function is meant or how it is measured.
Young cooling response
The pattern and amount of heat removal used as a reference from young people. It is a comparison standard rather than a single fixed biological state, and the supplied material gives no operational definition.
Selective reduction
A change intended to lower resistance to evaporation while preserving other relevant functions. Whether that separation is possible is part of the question, not an established property of the treatment.
Blood flow
The movement of blood through tissue. In this question, a favourable skin blood-flow measurement is an indirect indicator whose improvement does not by itself establish actual heat removal.
Skin sensitivity
The skin's ability to detect sensations. The requested outcome includes preserving this ability, but the supplied material does not specify the sensations or measurements involved.
Tolerance of exertion
The ability to sustain physical activity under the conditions being assessed. It is a separate required outcome, with no supplied performance criterion.
Heat load and watts
Heat load is the rate at which heat must be managed by the body; a watt measures energy per second. The exercise-induced heat load reported by S5 describes that study's conditions, not a universal boundary.
Adjustment to heat
Changes occurring with repeated or sustained exposure to hot conditions. S6 concerns seasonal exposure, while S8 and S9 concern heat adjustment in other study settings; none establishes the proposed treatment mechanism.
Accumulated body heat
Heat retained in the body when heat gained or generated exceeds heat lost. S6 reports changes in this outcome, which is distinct from sweat production alone.
Temperature-responsive fabric
A material whose properties change with temperature. In S3, changes in how water wets its channels promote sweat movement and evaporation; the fabric is not evidence of the proposed effect in treated skin.
Dairy cows
Cattle kept for milk production. They are the animals studied in S2, so that finding does not directly establish human treatment effects.
Mongolian gerbils
A rodent species studied in S8. Its reported adjustment to heat involves reduced bodily heat production and does not establish how treated human skin loses heat.
What the question takes for granted
Premise not found in what was read
The therapy creates resistance to evaporation that causes an otherwise hidden loss of heat dissipation despite normal sweating and favourable blood-flow measurements.

The treatment is an unspecified intervention intended to improve middle-aged skin, and the proposed resistance is an obstacle to sweat evaporating from its surface. The assumption is that this obstacle reduces cooling even when sweat production and blood flow appear satisfactory. If established, it would explain why improving those measurements alone might fail to restore youthful cooling.

The supplied search results do not establish this treatment-created obstacle or its causal contribution. S3 describes a fabric that promotes sweat transport and evaporative cooling, but does not test the proposed skin treatment or measure its resistance to evaporation. S5 and S7 report age-related limitations in heat loss without establishing the claimed mechanism. These limits leave the premise unsupported in the read sources, rather than showing that it is false.S3S5S7

The same question asked without the part nothing read establishes:

  • In treated middle-aged skin with normal sweat production, does reducing resistance to evaporation improve cooling while preserving the treatment's protective barrier effect?
  • Does the skin treatment change actual heat loss in middle-aged people even when sweat production and blood flow appear normal?
What turns on the answer
  • Cooling is restored and protection is preserved Under the proposed mechanism, reducing resistance would allow sweat to evaporate more readily and remove enough heat to reach the young reference response. Preserved protection would mean that the cooling benefit did not require sacrificing the treatment's barrier effect, although sensitivity and tolerance of exertion would remain separate requirements.
  • Cooling improves but remains below the young response If the change acts selectively on resistance, this outcome would indicate that resistance contributes to the cooling limitation but does not explain all of it. Normal sweat production together with improved evaporation would still be insufficient to establish the complete functional restoration requested.
  • Cooling does not improve If resistance were successfully reduced without changing other relevant conditions, unchanged heat loss would weigh against it being the limiting step under those conditions. The proposed route from easier evaporation to restored youthful cooling would therefore remain unfulfilled.
  • Cooling improves but protection is lost Easier evaporation would increase heat removal, but the same change would weaken the protective effect the treatment is intended to retain. Improved cooling alone would therefore fail the question's combined requirement.
Why it matters

The proposed explanation separates sweat production from the evaporation through which sweat removes heat. If a treatment obstructs that second step, normal sweat production could give a misleading impression of restored cooling; this is the question's proposed mechanism, not a finding established by the supplied sources. Reducing the obstruction would meet the stated goal only if cooling improved while the protective barrier, sensitivity and tolerance of exertion remained intact. Assuming this explanation without evidence could also misattribute reduced cooling: S7 reports age-associated reductions in sweat production that compromise heat loss, rather than a treatment-created obstacle to evaporation.

What is already established

Узлы RL-1/RL-2 описывают потоотделение, кровоток и тканевые связи; их отдельная нормализация не устанавливает фактическую .

What would have to be true

Совместный молодой тепловой ответ в заданном минутном окне с , чувствительности и переносимости нагрузки.

What is missing

Не определён причинный вклад в функциональный провал при благоприятных показателях и кровотока.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Повторные на фоне терапии накапливают химическое повреждение системы в кожных сосудах. Предполагаемый представляет собой , нарушающую его . Начальное и сохраняются, однако поддержание в течение минутной нагрузки постепенно ухудшается. Состояние определяется предшествующей последовательностью нагрузок и сохраняется после смены . Восстановление должно стабилизировать без вмешательства в .

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

, : D = Σ_i n_i/N_i, предполагаемый D = 1. Источник: [Miner, Cumulative Damage in , 1945](https://doi.org/10.1115/1.4009458). Здесь i обозначает заранее определённый класс с фиксированными , длительностью и паузой; n_i является числом выполненных циклов этого класса; N_i является независимо измеренным числом таких циклов до заданного снижения устойчивого ; D является накопленной долей химического повреждения. Переносится проверяемое правило суммирования повреждений. Трещины, разрывы матрикса и изменение не постулируются. Модель применяют только в окне, где восстановление между циклами пренебрежимо мало. Её дополнительное предсказание: перестановка одинакового набора циклов сохраняет результат; обнаружение опровергает именно .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В определяют число одинаковых до заранее установленного ухудшения . Затем без повторной предсказывают результат смешанных последовательностей по сумме . При одинаковом текущем и одинаковой финальной нагрузке дефицит должен зависеть от накопленной суммы, сопровождаться изменением показателей и сохраняться после увеличения . Восстановление должно улучшить ответ независимо от . Отсутствие химического изменения и при достаточной точности измерений опровергает предложенный механизм.

States a measurable outcome; comparing rivals needs more conditions. The text specifies observable dependencies, persistence and improvement conditions, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Биологическая опора ограничена отдельными звеньями. У людей среднего возраста выявлено снижение зависимой от реакции на нагревание: [первичное исследование](https://pmc.ncbi.nlm.nih.gov/articles/PMC3378394/). В коже людей с исследовали восстановление с разделением и : [исследование ](https://pmc.ncbi.nlm.nih.gov/articles/PMC3543657/). Эти результаты не доказывают повреждение от бытовых . Его сначала проверяют на ; отсутствие такого повреждения будет содержательным .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В определяют число одинаковых до заранее установленного ухудшения . Затем без повторной предсказывают результат смешанных последовательностей по сумме . При одинаковом текущем и одинаковой финальной нагрузке дефицит должен зависеть от накопленной суммы, сопровождаться изменением показателей и сохраняться после увеличения . Восстановление должно улучшить ответ независимо от . Отсутствие химического изменения и при достаточной точности измерений опровергает предложенный механизм.

  • What would separate them

    Synchronizing local blood-flow and sweating rhythms may restore youthful skin heat loss predicts: При постоянной умеренной одновременно регистрируют отдельные , кровоток, температуру кожи и фактический . Затем с одинаковой задают синхронно с либо . Гипотеза предсказывает воспроизводимое восстановление минутной только при синхронном режиме, включая сохранение эффекта при постоянной местной после прерывания переменного . Более паропроницаемый без исправления не обеспечивает полного восстановления. Отсутствие зависимости от при подтверждённом изменении опровергает гипотезу.

  • What would separate them

    Therapy may reduce net body heat loss by absorbing more sunlight and converting it to heat predicts: В независимо меняют освещение и состава при сопоставимой . Гипотеза предсказывает быстрое появление дополнительного под излучением и его исчезновение при после учёта . Величина дефицита должна соответствовать отдельно измеренному приросту всей системы «покрытие и кожа». и предшествующее число не устраняют этот компонент. Если измеренная дополнительная существенно меньше , гипотеза как его основное объяснение отвергается.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.